Bile acid dysregulation in sepsis: mechanisms, clinical implications, and future perspectives
Frontiers in Cellular and Infection Microbiology · 05.08.2026 · 16
DOI: 10.3389/fcimb.2026.1752527 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cellular and Infection Microbiology, online erschienen am 05.08.2026. Verfasst von Jing Wang und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency Intensive Care Unit (EICU), The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu, China. Hauptthemen laut MEDLINE: Sepsis, Bile Acids and Salts. Die Arbeit nennt 154 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Sepsis
Abstract (Originalsprache)
Sepsis is a life-threatening syndrome caused by a dysregulated host response to infection and remains a major global health challenge because of its high morbidity, mortality, and limited targeted therapeutic options. Accumulating evidence suggests that bile acids (BAs), endogenous metabolites synthesized in the liver and modified by the gut microbiota, are involved in inflammation, barrier integrity, and metabolic homeostasis. Sepsis is associated with alterations in multiple aspects of BA homeostasis, including hepatic synthesis, transporter activity, microbial biotransformation, and enterohepatic circulation. These alterations may influence hepatic function, gut barrier integrity, and immune responses, although their precise role in sepsis progression remains incompletely understood. This review summarizes current advances in BA biology relevant to sepsis, discusses the interactions between BA dysregulation and the liver–gut–microbiota–immune axis, and evaluates the potential and current limitations of BA-related biomarkers and therapeutic strategies. Particular emphasis is placed on unresolved issues, including disease heterogeneity, causality, and clinical translation. By synthesizing current evidence and knowledge gaps, this review provides an updated perspective on BA dysregulation within the broader immunometabolic landscape of sepsis and highlights priorities for future research.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency Intensive Care Unit (EICU), The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu, China.
- School of Nursing, Faculty of Medicine, Yangzhou University, Yangzhou, China.
- Department of Intensive Care, The Affiliated Hospital of Yangzhou University, Yangzhou University, Yangzhou, Jiangsu, China.
- The First School of Clinical Medicine, Faculty of Medicine, Yangzhou University, Yangzhou, China.
Zitieren
APA
Wang, J., Xia, L., Xu, S., Wu, F., Shi, S., Wang, Y., Wei, Y., Li, J., Zhang, X., Chen, X., Zhu, M., & Zhuang, J. (2026). Bile acid dysregulation in sepsis: mechanisms, clinical implications, and future perspectives. Frontiers in Cellular and Infection Microbiology, 16. https://doi.org/10.3389/fcimb.2026.1752527
Vancouver
Wang J, Xia L, Xu S, Wu F, Shi S, Wang Y, et al. Bile acid dysregulation in sepsis: mechanisms, clinical implications, and future perspectives. Frontiers in Cellular and Infection Microbiology. 2026;16. doi:10.3389/fcimb.2026.1752527
BibTeX
@article{Wang2026,
author = {Wang, Jing and Xia, Le and Xu, Siyao and Wu, Fei and Shi, Suqin and Wang, Yurong and Wei, Yu and Li, Jiaqi and Zhang, Xiaojie and Chen, Xiaoxiao and Zhu, Min and Zhuang, Jinqiang},
title = {Bile acid dysregulation in sepsis: mechanisms, clinical implications, and future perspectives},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2026},
volume = {16},
doi = {10.3389/fcimb.2026.1752527}
}
EUVIMED